Search Results for: Roche
Weekly in Asia(0407-0413)
2019-04-19
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Weekly Top 5 in China (0224-0302)
2019-03-11
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Things you must know about the 10-minute universal cancer test
2018-12-11
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
BioTaiwan 2018: Catching A Glimpse of Biotech Business in Asia
2018-08-01
Biomarkers – Essentials of the Immunotherapy Toolbox
2018-07-24
The Amazing Era of the Second Brain
2018-07-14
1 17 18 19 20
Scroll to Top